Recurrent Melanoma Active Not Recruiting Phase 2 Trials for Dinaciclib (DB12021)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00937937Dinaciclib in Treating Patients With Stage IV MelanomaTreatment